ClinicalTrials.gg
RecruitingNCT07520929Updated Apr 9, 2026

Acute Sauna Session and Glucose Control

An interventional study of Infrared sauna session and Resting condition in Obesity & Overweight, sponsored by University of Prince Edward Island. Recruiting at 1 site in Canada. Open to participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by University of Prince Edward Island · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Dec 2025, registered Apr 2026).
  • Started Dec 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
30 Years to 55 Years
Sex
All
01

Study summary

The goal of this clinical trial is to examine the effect of a single 40-minute sauna session on glucose control in individuals at risk for metabolic impairments.

Research Questions:

  • Can a single sauna session completed before a meal reduce the post-meal blood glucose response?
  • Can a single sauna session improve 24-hour glucose control?

Study Design:

Participants will complete two lab visits: one involving a sauna session and one placebo visit (resting condition). Researchers will compare the effects on glucose control using a continuous glucose monitor (CGM).

What Participants Will Do:

Attend a sauna familiarization session Have a CGM sensor placed on the upper arm Visit the lab twice (once for sauna, once for placebo) Consume three standardized meals at home after each session

Read the detailed description

At least 72 hours prior to the first trial, participants will complete a familiarization session consisting of two 20-minute infrared sauna exposures. The study employs a randomized crossover design, with each participant completing both experimental conditions-infrared sauna (two 20-minute sessions at 175°F / 79°C, separated by a 5-minute break) and seated rest (two 20-minute periods of quiet sitting, separated by a 5-minute break)-separated by at least 72 hours. On each trial day, participants will arrive at the laboratory at 7:50 a.m. after an overnight fast from 8:00 p.m., with water permitted throughout. Participants will wear a continuous glucose monitor (CGM) during both trial days. Baseline measurements of blood pressure, heart rate, and oral body temperature will be recorded, and food logs reviewed. Following the condition session, a sedentary recovery period will occur until 9:45 a.m., with repeated physiological measurements. Final measurements of blood pressure, heart rate, and oral body temperature will be collected prior to a standardized breakfast provided from 9:45 to 10:10 a.m. Participants will depart thereafter by car or public transportation and remain sedentary for the remainder of the day. Meals for the rest of the day, i.e., breakfast, lunch, dinner, and a bedtime snack, will be provided and identical across trial days. Participants will fast again from 9:00 p.m. until 9:00 a.m. the following morning.

02

Conditions studied

  • Obesity & Overweight

Keywords

  • sauna
  • heat-therapy
  • obesity
  • overweight
  • continuous glucose monitoring
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 15 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Prince Edward Island is the lead sponsor of 13 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Are 30-55 years old

Have a of ≥ 27 kg/m2

Have a waist size >102 cm (men) or >88 cm (women)

Have access to transportation for the 2 experimental visits (e.g., car, public transit, or drop-off).

Are cleared for participation based on the Physical Activity Readiness Questionnaire (PAR-Q+).

Exclusion criteria

Exclusion Criteria:

Take medications that affect blood sugar

Exercise intensely 2+ times/week

Have diabetes, heart issues, low blood sugar or pressure

Are pregnant

Regularly use saunas or other heat therapy 1+ times/week

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Sauna

    Infrared sauna session

    Other: Infrared sauna session

  • Placebo comparator
    Resting control

    Seated resting session

    Other: Resting condition

Interventions

  • OtherInfrared sauna session

    Infrared sauna session (approximately 165°F; two 20-minute sessions separated by a 5-minute rest outside the sauna)

  • OtherResting condition

    Seated resting session (45 minutes outside the sauna)

06

What researchers measure

Primary outcomes

  1. Incremental 2-hour postprandial glucose area under the curve (Breakfast)

    2-hour postprandial incremental AUC of CGM glucose above baseline, measured after the standardized breakfast consumed 45 minutes following the sauna or resting (control) session.

    Time frame: 2 hours

Secondary outcomes

  1. 2-hour postprandial glucose area under the curve (Breakfast)

    2-hour postprandial AUC of CGM glucose above baseline, measured after the standardized breakfast consumed 45 minutes following the sauna or resting (control) session.

    Time frame: 2 hours

  2. Incremental 2-hour postprandial glucose area under the curve (Lunch)

    Incremental 2-hour postprandial AUC of CGM glucose above baseline, measured after the standardized lunch consumed 225 minutes following the sauna or resting (control) session.

    Time frame: 2 hours

  3. Incremental 2-hour postprandial glucose area under the curve (Dinner)

    Incremental 2-hour postprandial AUC of CGM glucose above baseline, measured after the standardized lunch consumed 435 minutes following the sauna or resting (control) session.

    Time frame: 2 hours

  4. Incremental 2-hour postprandial glucose area under the curve (Bedtime snack)

    Incremental 2-hour postprandial AUC of CGM glucose above baseline, measured after the standardized lunch consumed 645 minutes following the sauna or resting (control) session.

    Time frame: 2 hours

  5. Average incremental 2-hour postprandial glucose area under the curve (4 meals)

    Average incremental 2-hour postprandial CGM glucose AUC above baseline, measured after each standardized meal consumed following the sauna or resting (control) session. The incremental AUC for all four meals will be summed and divided by four to calculate the average incremental postprandial response.

    Time frame: 2 hours

  6. Time below range

    Total time (minutes) during which CGM glucose values remained below 3.9 mmol/L over the 24-hour period following the sauna or resting (control) session.

    Time frame: 24 hours

  7. Time above range

    Total time (minutes) during which CGM glucose values remained above 7.8 mmol/L over the 24-hour period following the sauna or resting (control) session.

    Time frame: 24 hours

  8. Time in range

    Total time (minutes) during which CGM glucose values remained between 3.9 and 7.8 mmol/L over the 24-hour period following the sauna or resting (control) session.

    Time frame: 24 hours

  9. Session-induced delta glucose

    Change in CGM glucose during the 45-minute sauna or resting (control) session, calculated as the difference between post-session and pre-session values (Δ = post - pre).

    Time frame: 45 minutes

  10. Fasting glucose

    CGM glucose representing fasting levels the morning after the sauna or resting (control) session, computed as the mean glucose over the 15 minutes preceding the standardized breakfast.

    Time frame: 15 minutes

  11. Daily mean glucose

    CGM glucose average over the 24h period following the sauna or resting (control session).

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
  • University of Prince Edward Island
    Charlottetown, Prince Edward Island C1A 4P3, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 12 months after the start.

Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
Apr 9, 2026
StartActual
Dec 1, 2025
Primary completionEst.
Dec 15, 2026
CompletionEst.
Apr 15, 2027
Last update
Apr 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07520929
Lead sponsor
University of Prince Edward Island
Collaborators
DexCom, Inc.
Responsible party
Sponsor
First posted
Apr 9, 2026
Start date
Dec 1, 2025
Primary completion
Dec 15, 2026 (estimated)
Completion
Apr 15, 2027 (estimated)
Last update
Apr 9, 2026

Study contacts

Etienne Myette-Cote, PhD
Contact
emyette-cote@upei.ca
9025660756
Romina Babazadeh, MSc
Contact
rbabazadeh@upei.ca
9026205034
Etienne Myette-Cote
principal investigator · University of Prince Edward Island

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion